Lithium has been in the service of psychiatry now for over thirty years. After being established as an effective therapeutic agent for the treatment of primary affective disorder, the drug is becoming increasingly popular. Consequently, valid concern has been generated into the study of hazards of long-term lithium therapy. Goitre, hypothyroidism (Lindstedt et al., 1977) and nephrogenic diabetes insipidus (Hestbech et al., 1977) have been variously reported. Memory and cognitive impairment as possible long-term hazards of lithium prophylaxis are also attracting considerable research attention. Various reports which have been published underscore one relevant point : that there is a definite lack of consensus regarding the cognitive side-efiects of lithium. Christodoulou et al. (1981) studied the memory functions in patients taking lithium on the day before lithium was discontinued and again 16 days later. Benton's visual retention test showed the most clear-cut significant improvement. They, however, had a small sample and memory dysfunction was not revealed by all tests. Squire et al. (1980) concluded that lithium treatment in their study did not significantly affect performance on formal tests of learning and memory, although it does appear to cause slowing of performance, thereby affecting those tests requiring speed. Engelsmann (1980) reported that long-term lithium carbonate therapy does not affect cognitive functioning. Ghadirian et al. (1980) observed no significant relationship between duration of lithium treatment and the scores on WMS and Benton Visual Retention Test. Their results brought no conclusive evidence of memory impairment in patients treated with lithium, except for a trend in the long term group of poorer recall of visual test material. There was no difference in M.Q_. between the short and longterm groups. Tyrer and Shopsin (1980) suggest that some impairment of learning in patients receiving lithium does occur and this is also manifested by abnormal EEGs. However, they report that a similar complaint of impaired memory is also seen in some patients receiving tricyclic antidepressants. Sugumar et al. (1980) , in the only available Indian study, report that short-term recall at 3 and 9 seconds did not suffer, whereas at the 15 seconds interval there was a significant difference. Judd (1979) found performance deficits after 14 days of lithium carbonate estimation. Telford and Worrall (1978) concluded that under usual circumstances of lithium prophylaxis there is no impairment of intellectual functioning to any significant extent. The results of Kusumo and Vaughan (1979) indicate that patients taking lithium show an impairment of recall at a delay interval which approaches the limits of short term memory functioning. Thus, these and other contradicting reports have prompted us to take up the issue for ourselves and help in an elucidation of the problem.
The present study was undertaken with the following aims :
1. Each patient was subjected to a detailed evaluation with the help of a semi-structured proforma. After this initial clinical evaluation, the experimental group was administered the following 2 scales in order to de-fine the affective state :
1. HRSD (Hamilton Rating Scale for Depression) 2. YMRS (Young's Mania Rating Scale). The Group-B subjects were administered the CMI. All patients and subjects were then assessed for intellectual and memory functions with the help of the following instruments :
1 Table- -1 shows that the majority of experimental and contiol subjects belonged to the age-range 30 and 45 yrs. Most were educated upto class XII, while a major proportion of the sample consisted of graduates. They were either occupied in service or business. A very small percentage was made up of students. The sample consisted of male subjects only : Statistical analysis reveals that the experimental and control These tables indicate a high degree of correlation between the I.Q,. and M.Q,. scores in both experimental and control groups. This table shows the mean M.Q,. and I.Q,. of the experimental and control groups. A statistical comparison shows that there are no significant differences in these areas between the two groups.
Table-III shows that the experimental and control groups performed equally well on the individual WMS subscales. There were no statistically significant differences. "Forgetting" is the difference between immediate recall and delayed reproduction. This table shows that there are no significant differences between the two groups on this variable.
For the purpose of the present study only such patients were included who had been taking litnium regularly. The possibility, that duration of lithium intake may adversely be related to memory and intelligence, was kept in mind. Moreover, if the supposed adverse effects are reversible then they are likely to improve with stoppage of lithium. Therefore, a precondition of "regular" intake was kept for inclusion so that a reliable comparison between the short-term (2 (1) 0.6-0.7
(2) 0.7-0.8 This Table shows the distribution of M.Q-and I.Q. in group-A subjects according to the serum lithium levels. It seems that higher levels of serum lithium, but well within the therapeutic range (0.6-1.2 mEq/Lit.), do not imply worsening of performance on memory and intelligence tests. (1)0.6-0.7 .. 13 6.88 2.00 9.69 2.87
(2) 0.7-0.8 .. As with the previous observations, there is no significant difference on Delayed Reproduction performance according to serum levels of lithium.
months-2 years) and long term (2 year -5 years) groups can be made. This Table shows the effect of duration of lithium intake on Delayed Reproduction. The mean scores on the two subtests, when compared between the short-term (2 months-2 years) and long-term (2 years-5 years) groups, show no significant differences, M.Q,. was greater for the group which was on lithium for 2 months to 2 years. Such was also the case for the mean I.Q,. score. Both M.Q. and I.Q. were, however, within the normal range and there was no statistically significant differences between the long and short-term groups on these scores.
DISCUSSION
The use of lithium salts in the successful management of manic-depressive psychosis has been fairly well-established (Bech etal., 1976; Fieveetal., 1975) . Schou etal. (1968) performed three experiments on normal subjects and found cognitive and affective disturbances when they took lithium for one to 3 weeks. Small et al. (1972) found no statistically significant differences in cognitive and affective functioning in 10 normal subjects taking lithium for 3 weeks.
In our study, we obtained a sample of index patients following the application of stringent inclusion and exclusion criteria and a group matched sample of controls. There appeared to be no impairment of memory functioning in patients who were taking lithium. Our results, here, are comparable with those of Ghadirian et al. (1980) who also administered the WMS tu 20 patients on long-term lithium therapy and 10 patients on short-teim. Various authors have reported memory impairment on certain specific memory tasks (Christodoulou et al., 1981 ; Ghadirian et al, 1980 and Squire et al., 1980) . We analysed the performance of patients and subjects on the seven components of WMS separately. No significant difference was found on any of the subtests. Logical Memory and Associate Learning were the two subtests on which we, obtained the maximum intergroup difference, though well within the limits of insignificance. Squire et al. (1980) were of the view that lithium causes a slowing of performance in the absence of impairment of learning and memory. Ananth et al. (1979) found no effect on cognitive functioning even after long term use in therapeutic doses. Judd et al. (1977) , like Squire et al. (1980) , also believe that the ' performance deficit may be due more to a lithium carbonate induced slowing than to a perfoimance disruption.
That lithium may cause memory impairment at higher doses has been reported by a few workers (Squire et al., 1980 and Judd, 1980 ). In our study the level of serum lithium did not affect any test significantly. Reus et al. (1979) had a similar conclusion. Studies by Zokowaska Dabrowska and Rybakowski (1973), Spring et al. (1970) , Shopsin ct al. (1970) and Agulnik et al. (1972) indicate that the effects of lithium on memory functions are more likely to occur when the serum levels are beyond the therapeutic range. Secondly, toxicity due to lithium may occur in some patients even in the therapeutic range of serum levels. These factors may be implicated as having a role in those reports where lithium has been found to affect memory functions adversely. Again, like Ghadirian et al. (1980) , we were not able to fird any relationship between memory functions and duration of lithium treatment.
The results of this study are, thus, in agreement with those studies which have found no effect of prophylactic lithium therapy upon memory functions.
